UroMems

UroMems develops innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI). Their flagship product, UroActive, is a smart automated artificial urinary sphincter designed to improve patient outcomes and address unmet needs in SUI treatment. The technology is protected by over 150 patents.


Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $47M

Date: 25-Jun-2024

Investors: Crédit Mutuel Innovation, European Innovation Council, Wellington Partners, Bpifrance, Supernova Invest, Hil-Invent, b-to-v Partners, Financière Arbevel

Markets: Medtech, Healthtech

HQ: Grenoble, Auvergne-Rhône-Alpes, France

Founded: 2011

Website: https://www.uromems.com

LinkedIn: https://www.linkedin.com/company/uromems/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/uromems

Pitchbook: https://pitchbook.com/profiles/company/168192-10


Leave a Comment